|1.||Assimadi, J K: 2 articles (07/2001 - 01/2000)|
|2.||Tanaka, Tsuyoshi: 1 article (12/2015)|
|3.||Udagawa, Harushi: 1 article (12/2015)|
|4.||Haruta, Shusuke: 1 article (12/2015)|
|5.||Ohkura, Yu: 1 article (12/2015)|
|6.||Iizuka, Toshiro: 1 article (12/2015)|
|7.||Ueno, Masaki: 1 article (12/2015)|
|8.||Kato, Gregory J: 1 article (01/2012)|
|9.||Brooks, Adrian: 1 article (07/2011)|
|10.||Howard, Joanna: 1 article (07/2011)|
12/01/1986 - "These observations strongly suggest that the intracavernous injection of etilefrine hydrochloride is effective in treating not only iatrogenic priapism but also priapism due to other etiologies. "
07/03/1999 - "Etilefrin can be proposed as first line treatment for priapism in sickle-cell patients (at least in cases lasting less than 24 h). "
05/01/2005 - "We describe a case of a young patient with recurrent idiopathic priapism who has used etilefrine self-injection for the past 10 years with good efficacy and libido and erectile function preservation. "
05/01/2005 - "Intracavernosal etilefrine self-injection therapy for recurrent priapism: one decade of follow-up."
07/01/2001 - "Management of sickle cell priapism with etilefrine."
|2.||Hypotension (Low Blood Pressure)
03/01/2000 - "This study was designed to determine the efficacy of oral etilefrine in preventing hypotension induced by spinal anaesthesia. "
03/01/2000 - "Hypotension was defined as a 30% decrease from base-line for systolic arterial pressure and mean arterial pressure or systolic value <90 mmHg, and was treated with intravenous boluses of etilefrine 2 mg. The overall incidence of spinal anaesthesia induced hypotension was 25%, ranging from 20% in the etilefrine group to 30% in the control group. "
09/01/1976 - "[Value of fetanol in the complex treatment of pregnant women with arterial hypotension]."
09/01/1973 - "[Use of phetanol in hypotension]."
01/01/1971 - "[The effect of phetanol on the contractile function of the myocardium in arterial hypotension]."
01/01/1995 - "Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo."
03/23/1999 - "Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. "
08/15/2000 - "Effects of intravenous etilefrine in neurocardiogenic syncope induced by head-up tilt testing."
03/23/1999 - "Oral etilefrine is not superior to placebo in preventing spontaneous episodes of vasovagal syncope. "
03/23/1999 - "Etilefrine is an alpha-agonist agent with a potent vasoconstrictor effect, which is potentially useful in preventing vasovagal syncope by reducing venous pooling and/or by counteracting reflex arteriolar vasodilatation. "
07/01/2001 - "Intracavernous injections of etilefrine were effective in seven children with acute sickle cell priapism, and stuttering priapism resolved in five children after one to seven months of oral etilefrine. "
07/01/2011 - "We describe a randomized, placebo-controlled, clinical study looking at medical prophylaxis with 2 oral α-adrenergic agonists, etilefrine and ephedrine, in preventing stuttering attacks of priapism. "
05/01/1996 - "Because of the dominant vasodepressor reaction, Effortil was started to prevent further syncope, with good results."
01/01/1995 - "This was a randomized double-blind crossover study of etilefrine versus placebo in 30 consecutive patients with syncope and a baseline positive head-up tilt test. "
03/23/1999 - "In the 20 participating centers, 126 patients with recurrent vasovagal syncope (at least 3 episodes in the last 2 years) and a positive baseline head-up tilt response were randomly assigned to placebo (63 patients) or etilefrine at a dosage of 75 mg/d (63 patients) and were followed up for 1 year or until syncope recurred. "
10/01/1984 - "Although blood pressure was maintained by administering etilefrine and hydrocortisone, syncope persisted. "
03/01/1990 - "Eight of these 10 patients underwent serial head-up tilt tests after atropine (0.04 mg/Kg i.v. in 1 minute), propranolol (0.2 mg/Kg i.v. in 3 minutes) and etilefrin (15-30 mg/day orally for 2-3 days) to determine the pathogenesis of vaso-vagal syncope. "
|2.||Adrenergic Agonists (Adrenergic Receptor Agonist)
|6.||Adrenergic Agents (Adrenergic Drugs)
|3.||Cesarean Section (Caesarean Section)